Clinical Trial Update: Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS) [NA]

View source ↗

Summary

Update indicates Medtronic's Deep Brain Stimulation therapy for epilepsy (EPAS) post-approval study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Medtronic Deep Brain Stimulation Therapy

Snippet

Sponsor: MedtronicNeuro | Conditions: Epilepsy | NA | Status: TERMINATED